Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Oct 23, 2006

BrainCells and Organon Collaborate on CNS Drugs

  • BrainCells and Organon will collaborate in the discovery and development of drugs for the treatment of central nervous system disorders.

    BrainCells will use its technology in the area of neurogenesis to identify neuroscience applications for compounds formerly in the Organon clinical-stage pipeline. When BrainCells determines the therapeutic utility for a drug candidate, the companies will work together to develop and reposition the drug for its new use.



Be sure to take the GEN Poll

CRISPR Patent Controversy

Do you think recently released email from a former Broad Institute scientist to Jennifer Doudna will expedite a final legal decision on who owns the CRISPR patent?

More »